Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern

European Journal of Immunology

Volumn 41, Issue 2, 2011, Pages 450-460

  Vander Beken, Seppe ^a   Al Dulayymi, Juma'a R ^b   Naessens, Thomas ^a   Koza, Gani ^b   Maza Iglesias, Max ^b   Rowles, Richard ^b   Theunissen, Cornelia ^b   De Medts, Jelle ^a   Lanckacker, Ellen ^c   Baird, Mark S ^b   Grooten, Johan ^a  

^a GHENT UNIVERSITY   (Belgium)

^b BANGOR UNIVERSITY   (United Kingdom)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Alveolar macrophage; Mycobacterium tuberculosis; Mycolic acid; Pulmonary inflammation

Indexed keywords

CYCLOPROPANE; MYCOLIC ACID; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL WALL; BRONCHUS DISEASE; CHEMICAL STRUCTURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; INNATE IMMUNITY; ISOMER; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXYGENATION; PNEUMONIA; PRIORITY JOURNAL; STEREOCHEMISTRY;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; FEMALE; GENE EXPRESSION; IMMUNITY, INNATE; INFLAMMATION; LIPOSOMES; LUNG; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; MYCOLIC ACIDS; NEUTROPHILS; STEREOISOMERISM; VIRULENCE FACTORS;

EID: 78851469937     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040719     Document Type: Article

References (64)

1. Daffe, M., Laneelle, M. A., Asselineau, C., Levyfrebault, V. and David, H., Taxonomic value of Mycobacterial fatty-acids: proposal for a method of analysis. Ann. Microbiol. 1983. B134: 241-256.
2. Kremer, L. S. and Besra, G. S., Current status and future development of antitubercular chemotherapy. Expert Opin. Investig. Drugs 2002. 11: 1033-1049.
3. Brennan, P. J., Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis 2003. 83: 91-97.
4. Hunter, R. L., Olsen, M. R., Jagannath, C. and Actor, J. K., Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann. Clin. Lab. Sci. 2006. 36: 371-386.
5. Karakousis, P. C., Bishai, W. R. and Dorman, S. E., Mycobacterium tuberculosis cell envelope lipids and the host immune response. Cell. Microbiol. 2004. 6: 105-116.
6. Ryll, R., Kumazawa, Y. and Yano, I., Immunological properties of trehalose dimycolate (cord factor) and other mycolic acid-containing glycolipids - a review. Microbiol. Immunol. 2001. 45: 801-811.
7. Ojha, A. K., Baughn, A. D., Sambandan, D., Hsu, T., Trivelli, X., Guerardel, Y., Alahari, A. et al., Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol. Microbiol. 2008. 69: 164-174.
8. Ojha, A. K., Trivelli, X., Guerardel, Y., Kremer, L. and Hatfull, G., Enzymatic hydrolysis of trehalose dimycolate releases free mycolic acid during mycobacterial growth in biofilms. J. Biol. Chem. 2010. 285: 17380-17389.
9. Korf, J., Stoltz, A., Verschoor, J., De Baetselier, P. and Grooten, J., The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses. Eur. J. Immunol. 2005. 35: 890-900.
10. Russell, D. G., Cardona, P. J., Kim, M. J., Allain, S. and Altare, F., Foamy macrophages and the progression of the human tuberculosis granuloma. Nat. Immunol. 2009. 10: 943-948.
11. Korf, J. E., Pynaert, G., Tournoy, K., Boonefaes, T., Van Oosterhout, A., Ginneberge, D., Haegeman, A. et al., Macrophage reprogramming by mycolic acid promotes a tolerogenic response in experimental asthma. Am. J. Respir. Crit. Care Med. 2006. 174: 152-160.
12. Pan, J., Fujiwara, N., Oka, S., Maekura, R., Ogura, T. and Yano, I., Anti-cord factor (trehalose 6, 6'dimycolate) IgG antibody in tuberculosis patients recognizes mycolic acid subclasses. Microbiol. Immunol. 1999. 43: 863-869.
13. Schleicher, G. K., Feldman, C., Vermaak, Y. and Verschoor, J. A., Prevalence of anti-mycolic acid antibodies in patients with pulmonary tuberculosis co-infected with HIV. Clin. Chem. Lab. Med. 2002. 40: 882-887.
14. Watanabe, M., Aoyagi, Y., Mitome, H., Fujita, T., Naoki, H., Ridell, M. and Minnikin, D. E., Location of functional groups in mycobacterial meromycolate chains; the recognition of new structural principles in mycolic acids. Microbiology 2002. 148: 1881-1902.
15. Watanabe, M., Aoyagi, Y., Ridell, M. and Minnikin, D. E., Separation and characterization of individual mycolic acids in representative mycobacteria. Microbiology (Reading, England) 2001. 147: 1825-1837.
16. Minnikin, D. E., Parlett, J. H., Magnusson, M., Ridell, M. and Lind, A., Mycolic acid patterns of representatives of Mycobacterium-Bovis Bcg. J. Gen. Microbiol. 1984. 130: 2733-2736.
17. Wong, M. Y. H., Steck, P. A. and Gray, G. R., Major mycolic acids of Mycobacterium-Smegmatis - characterization of their homologous series. J. Biol. Chem. 1979. 254: 5734-5740.
18. Minnikin, D. E. and Polgar, N., Methoxymycolic and ketomycolic acids from human Tubercle Bacilli. Chem. Commun. 1967. 22: 1172-1174.
19. Levyfrebault, V., Goh, K. S. and David, H. L., Mycolic acid analysis for clinical-identification of Mycobacterium-Avium and related Mycobacteria. J. Clin. Microbiol. 1986. 24: 835-839.
20. Dubnau, E., Chan, J., Raynaud, C., Mohan, V. P., Laneelle, M. A., Yu, K. M., Quemard, A. et al., Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol. Microbiol. 2000. 36: 630-637.
21. Vyas, S. P. and Khatri, K., Liposome-based drug delivery to alveolar macrophages. Expert Opin. Drug Deliv. 2007. 4: 95-99.
22. Hernandez-Pando, R., Orozco, H., Arriaga, K., Sampieri, A., Larriva-Sahd, J. and Madrid-Marina, V., Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis. Immunology 1997. 90: 607-617.
23. Welsh, K. J., Abbott, A. N., Hwang, S. A., Indrigo, J., Armitige, L. Y., Blackburn, M. R., Hunter, R. L., Jr., and Actor, J. K., A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6, 6'-dimycolate induced granulomatous response. Microbiology (Reading, England) 2008. 154: 1813-1824.
24. Raes, G., Brys, L., Dahal, B. K., Brandt, J., Grooten, J., Brombacher, F., Vanham, G. et al., Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. J. Leukoc. Biol. 2005. 77: 321-327.
25. Martinez, F. O., Helming, L. and Gordon, S., Alternative activation of macrophages: An immunologic functional perspective. Annu. Rev. Immunol. 2009. 27: 451-483.
26. Asseline, C., Tocanne, G. and Tocanne, J. F., Stereochemistry of mycolic acids. Bull. Soc. Chim. France 1970. 4: 1445-1449.
27. Minnikin, D. E., Kremer, L., Dover, L. G. and Besra, G. S., The methyl-branched fortifications of Mycobacterium tuberculosis. Chem. Biol. 2002. 9: 545-553.
28. Minnikin, D. E., Kusamran, K. and Polgar, N., Structure and distribution of mycolic acids of Mycobacteria. J. Gen. Microbiol. 1971. 68: iii-iv.
29. Minnikin, D. E. and Minnikin, S. M., Nuclear magnetic-resonance studies on the mycolic acids. J. Am. Oil Chem. Soc. 1980. 57: A163-A163.
30. Minnikin, D. E. and Polgar, N., Studies on the mycolic acids from human tubercle bacilli. Tetrahedron Lett. 1966. 23: 2643-2647.
31. Minnikin, D. E. and Polgar, N., Stereochemical studies on mycolic acids. Chem. Commun. 1966. 18: 648-649.
32. Minnikin, D. E. and Polgar, N., Mycolic Acids from Human and Avian Tubercle Bacilli. Chem. Commun. 1967. 18: 916-918.
33. Minnikin, D. E. and Polgar, N., Structural Studies on Mycolic Acids. Chem. Commun. 1967. 7: 312-314.
34. Villeneuve, M., Kawai, M., Kanashima, H., Watanabe, M., Minnikin, D. E. and Nakahara, H., Temperature dependence of the Langmuir monolayer packing of mycolic acids from Mycobacterium tuberculosis. Biochim. Biophys. Acta 2005. 1715: 71-80.
35. Barkan, D., Liu, Z., Sacchettini, J. C. and Glickman, M. S., Mycolic acid cyclopropanation is essential for viability, drug resistance, and cell wall integrity of Mycobacterium tuberculosis. Chem. Biol. 2009. 16: 499-509.
36. Bhatt, A., Fujiwara, N., Bhatt, K., Gurcha, S. S., Kremer, L., Chen, B., Chan, J. et al., Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice. Proc. Natl. Acad. Sci. USA 2007. 104: 5157-5162.
37. Dao, D. N., Sweeney, K., Hsu, T., Gurcha, S. S., Nascimento, I. P., Roshevsky, D., Besra, G. S. et al., Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production. Plos Pathog. 2008. 4: e1000081.
38. Gao, L. Y., Laval, F., Lawson, E. H., Groger, R. K., Woodruff, A., Morisaki, J. H., Cox, J. S. et al., Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy. Mol. Microbiol. 2003. 49: 1547-1563.
39. Glickman, M. S., The mmaA2 gene of Mycobacterium tuberculosis encodes the distal cyclopropane synthase of the alpha-mycolic acid. J. Biol. Chem. 2003. 278: 7844-7849.
40. Glickman, M. S., Cox, J. S. and Jacobs, W. R., A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol. Cell 2000. 5: 717-727.
41. Rao, V., Fujiwara, N., Porcelli, S. A. and Glickman, M. S., Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J. Exp. Med. 2005. 201: 535-543.
42. Rao, V., Gao, F., Chen, B., Jacobs, W. R., Jr., and Glickman, M. S., Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulence. J. Clin. Invest. 2006. 116: 1660-1667.
43. Takayama, K., Wang, C. and Besra, G. S., Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin. Microbiol. Rev. 2005. 18: 81-101.
44. Yuan, Y., Zhu, Y., Crane, D. D. and Barry, C. E., 3rd., The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis. Mol. Microbiol. 1998. 29: 1449-1458.
45. Boshoff, H. I. and Barry Iii, C. E., Is the mycobacterial cell wall a hopeless drug target for latent tuberculosis? Drug Discov. Today Dis. Mech. 2006. 3: 237-245.
46. Peyron, P., Vaubourgeix, J., Poquet, Y., Levillain, F., Botanch, C., Bardou, F., Daffe, M. et al., Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog. 2008. 4: e1000204.
47. Al Dulayymi, J. R., Baird, M. S. and Roberts, E., The synthesis of single enantiomers of a meromycolic acid. Tetrahedron Lett. 2000. 41: 7107-7110.
48. Al Dulayymi, J. R., Baird, M. S. and Roberts, E., The synthesis of a single enantiomer of a major alpha-mycolic acid of Mycobacterium tuberculosis. Chem. Commun. 2003. 228-229.
49. Al Dulayymi, J. R., Baird, M. S. and Roberts, E., The synthesis of a single enantiomer of a major alpha-mycolic acid of M-tuberculosis. Tetrahedron 2005. 61: 11939-11951.
50. Al Dulayymi, J. R., Baird, M. S., Roberts, E., Deysel, M. and Verschoor, J., The first syntheses of single enantiomers of the major methoxymycolic acid of Mycobacterium tuberculosis. Tetrahedron 2007. 63: 2571-2592.
51. Al Dulayymi, J. R., Baird, M. S., Roberts, E. and Minnikin, D. E., The synthesis of single enantiomers of meromycolic acids from mycobacterial wax esters. Tetrahedron 2006. 62: 11867-11880.
52. Al Dulayymi, A. R., Al Dulayymi, J. R., Baird, M. S. and Koza, G., Simple 4-carbon and 5-carbon cyclopropane derivatives as synthons. Zhurnal Organicheskoi Khimii 1997. 33: 867-885.
53. Al-Dulayymi, J. R., Baird, M. S., Mohammed, H., Roberts, E. and Clegg, W., The synthesis of one enantiomer of the alpha-methyl-trans-cyclopropane unit of mycolic acids. Tetrahedron 2006. 62: 4851-4862.
54. Coxon, G. D., Al Dulayymi, J. R., Morehouse, C., Brennan, P. J., Besra, G. S., Baird, M. S. and Minnikin, D. E., Synthesis and properties of methyl 5-(1' R, 2' S)-(2-octadecylcycloprop-1-yl)pentanoate and other omega-19 chiral cyclopropane fatty acids and esters related to mycobacterial mycolic acids. Chem. Phys. Lipids 2004. 127: 35-46.
55. Coxon, G. D., Knobl, S., Roberts, E., Baird, M. S., Al Dulayymi, J. R., Besra, G. S., Brennan, P. J. and Minnikin, D. E., The synthesis of both enantiomers of lactobacillic acid and mycolic acid analogues. Tetrahedron Lett. 1999. 40: 6689-6692.
56. Koza, G. and Baird, M. S., The first synthesis of single enantiomers of ketomycolic acids. Tetrahedron Lett. 2007. 48: 2165-2169.
57. Koza, G., Rowles, R., Theunissen, C., Al-Dulayymi, J. R. and Baird, M. S., The synthesis of single enantiomers of trans-alkene-containing mycolic acids. Tetrahedron Lett. 2009. 50: 7259-7262.
58. Koza, G., Theunissen, C., Al Dulayymi, J. R. and Baird, M. S., The synthesis of single enantiomers of mycobacterial ketomycolic acids containing cis-cyclopropanes. Tetrahedron 2009. 65: 10214-10229.
59. Riley, L. W., Of mice, men, and elephants: Mycobacterium tuberculosis cell envelope lipids and pathogenesis. J. Clin. Invest. 2006. 116: 1475-1478.
60. Hunter, R. L., Olsen, M., Jagannath, C. and Actor, J. K., Trehalose 6, 6'-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice. Am. J. Pathol. 2006. 168: 1249-1261.
61. Schoenen, H., Bodendorfer, B., Hitchens, K., Manzanero, S., Werninghaus, K., Nimmerjahn, F., Agger, E. M. et al., Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J. Immunol. 184: 2756-2760.
62. Benadie, Y., Deysel, M., Siko, D. G., Roberts, V. V., Van Wyngaardt, S., Thanyani, S. T., Sekanka, G. et al., Cholesteroid nature of free mycolic acids from M. tuberculosis. Chemistry Phys. Lipids 2008. 152: 95-103.
63. Al Dulayymi, J. R., Baird, M. S., Maza-Iglesias, M., Vander Beken, S. and Grooten, J., The first unique synthetic mycobacterial cord factors. Tetrahedron Lett. 2009. 50: 3702-3705.
64. van Rijt, L. S., Kuipers, H., Vos, N., Hijdra, D., Hoogsteden, H. C. and Lambrecht, B. N., A rapid flow cytometric method for determining the cellular composition of bronchoalveolar lavage fluid cells in mouse models of asthma. J. Immunol. Methods 2004. 288: 111-121.